Physician

Adnan Mushtaq, M.D.

According to 2025 Medicare claims, Adnan Mushtaq, M.D. (NPI: 1467409284) practices infectious disease, with the plurality of this provider's patient population coming from Adams, IL. This provider's primary affiliated billing organization is BLESSING HOSPITAL (NPI: 1114471737; TIN: 370661183) and primary practice location at 62301-2834. Mushtaq is affiliated with the IRCCO (ACO ID: A2619), Caravan Collaborative Pathways (ACO ID: A4604), The Rural Advantage LLC (ACO ID: A5257), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Mushtaq's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 273 HCPCS/CPT codes, and received $21,979 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 319 prescription claims across 71 beneficiaries totaling $114,159 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 16 records totaling $341. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $24,825 to $21,979. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $51,407 and ending at $114,159. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	115	334	$24,825
2016	461	1,581	$107,871
2017	498	1,735	$132,264
2018	382	1,724	$126,053
2019	312	2,020	$113,705
2020	305	1,354	$98,592
2021	251	830	$60,245
2022	215	568	$41,077
2023	173	338	$21,510
2024	148	273	$21,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	93	$51,407
2016	122	708	$489,619
2017	128	650	$521,836
2018	80	234	$232,428
2019	58	209	$78,743
2020	37	135	$32,753
2021	30	127	$32,451
2022	56	252	$88,630
2023	71	268	$123,835
2024	71	319	$114,159

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	20	20	$103
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	66	69	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	58	79	$73
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	17	18	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	34	51	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	15	450	$59,347
Fosfomycin Tromethamine	Fosfomycin Tromethamine	26	939	$5,956
Cefepime Hcl	Cefepime Hcl	11	71	$1,561
Ethambutol Hcl	Ethambutol Hcl	26	644	$704
Cephalexin	Cephalexin	63	2,491	$456

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$341	Paratek Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adnan Mushtaq, M.D.?

Tedicare shows public-source Medicare data for Adnan Mushtaq, M.D. (NPI 1467409284), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adnan Mushtaq, M.D. have ACO affiliation data?

Adnan Mushtaq, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Caravan Collaborative Pathways (MSSP, ACO ID A4604), The Rural Advantage LLC (MSSP, ACO ID A5257), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Adnan Mushtaq, M.D.?

Adnan Mushtaq, M.D. is linked to BLESSING HOSPITAL (billing NPI 1114471737) in the available physician profile data.

Does Adnan Mushtaq, M.D. have Open Payments data?

Adnan Mushtaq, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.